Cargando…

肺癌筛查方法现状

Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the scr...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973412/
https://www.ncbi.nlm.nih.gov/pubmed/27760605
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14
_version_ 1783326625319878656
collection PubMed
description Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the screening, such as, high false-positive rates, overdiagnosis and radiation exposure. As another non-invasive tumor screening method, blood-based tumor markers showed a high sensitivity and specificity in early diagnosis of lung cancer in recent years. How to establish a comprehensive mode for lung cancer screening by use existing screening methods, we need more clinical research.
format Online
Article
Text
id pubmed-5973412
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59734122018-07-06 肺癌筛查方法现状 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is the leading cause of cancer mortality currently. Early diagnosis is crucial to the good prognosis of lung cancer. Evidence has shown that low-dose computed tomography (CT) screening can make the decline in the mortality of lung cancer. However, there are still many problems in the screening, such as, high false-positive rates, overdiagnosis and radiation exposure. As another non-invasive tumor screening method, blood-based tumor markers showed a high sensitivity and specificity in early diagnosis of lung cancer in recent years. How to establish a comprehensive mode for lung cancer screening by use existing screening methods, we need more clinical research. 中国肺癌杂志编辑部 2016-10-20 /pmc/articles/PMC5973412/ /pubmed/27760605 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14 Text en 版权所有©《中国肺癌杂志》编辑部2016 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 综述
肺癌筛查方法现状
title 肺癌筛查方法现状
title_full 肺癌筛查方法现状
title_fullStr 肺癌筛查方法现状
title_full_unstemmed 肺癌筛查方法现状
title_short 肺癌筛查方法现状
title_sort 肺癌筛查方法现状
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973412/
https://www.ncbi.nlm.nih.gov/pubmed/27760605
http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.14